Search results

The Epidemiologic Catchment Area (ECA) program of research was initiated in response to the 1977 report of the President's Commission on Mental Health. The purpose was to collect data on the prevalence and incidence of mental disorders and on the use of and need for services by the mentally ill. Independent research teams at five universities (Yale University, Johns Hopkins University, Washington University, Duke University, and University of California at Los Angeles), in collaboration with the National Institute for Mental Health, conducted the studies with a core of common questions and sample characteristics. The sites were areas that had previously been designated as Community Mental Health Center catchment areas: New Haven, Connecticut, Baltimore, Maryland, St. Louis, Missouri, Durham, North Carolina, and Los Angeles, California. Each site sampled over 3,000 community residents and 500 residents of institutions, yielding 20,861 respondents overall. The longitudinal ECA design incorporated two waves of personal interviews administered one year apart and a brief telephone interview in between (for the household sample). The diagnostic interview used in the ECA was the NIMH Diagnostic Interview Schedule (DIS), Version III (with the exception of the Yale Wave I survey, which used Version II). Diagnoses were categorized according to the DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 3rd Edition (DSM-III). Diagnoses derived from the DIS include manic episode, dysthymia, bipolar disorder, single episode major depression, recurrent major depression, atypical bipolar disorder, alcohol abuse or dependence, drug abuse or dependence, schizophrenia, schizophreniform, obsessive compulsive disorder, phobia, somatization, panic, antisocial personality, and anorexia nervosa. The DIS uses the Mini-Mental State Examination (MMSE), which measures cognitive functioning, as an indirect measure of the DSM-III Organic Mental Disorders. In the ECA survey, this diagnosis is called cognitive impairment.

This collection features data from 17,327 participants across 2,005 variables. Data from the Los Angeles, California, Catchment (UCLA) are not included. Baseline data (Wave 1) and Wave 2 data were linked to the National Death Index through 2007, which includes primary and contributing causes of death, International Classification of Disease (ICD) codes, and nature of injury variables.

This project was an investigation into the natural course of service needs, use, and trajectories among high-risk youth and young adults with drug use who presented to an inner-city Emergency Department with multiple risk behaviors (with and without acute violent injury). Eligible participants included youth/young adults (ages 14-24) who sought care at the Hurley Medical Center (HMC) Emergency Department (ED) located in Flint, Michigan between December 19, 2009 and September 7, 2011. Consenting youth completed a self-administered computerized screening survey. All participants who self-reported past year drug use were recruited for the longitudinal study. For a comparison group, a randomly selected sample of drug using youth seeking ED care for other reasons (e.g. abdominal pain, motor vehicle crash) were selected for longitudinal study (equilibrated monthly proportionally for age/gender with the acute violent injury group). Participants in the violent injury and comparison group completed a baseline assessment during their ED visit.

Dataset 1 (DS1) contains the Baseline Screener Data of both young adults and youth. This data file has 1,448 cases and 253 variables. Each case represents an individual seeking treatment in the emergency department.

Dataset 2 (DS2) contains the Baseline Youth Data. This data file has 89 cases and 363 variables. Of these 89 cases, 51 of the youths (ages 14-17) presented to the Emergency Department with a violent injury. The remaining 38 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.

Dataset 3 (DS3) contains the Baseline Young Adult Data. This file contains 511 cases and 380 variables. Of these 511 cases, 299 of the young adults (ages 18-24) presented to the Emergency Department with a violent injury. The remaining 212 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.

The Baseline Screener Data includes demographics and information about public assistance, income, work, marital status, insurance, the injury visit, school/grades, retaliation attitudes, fights, violence, gang affiliation, weapons, partner violence, nicotine use, alcohol use, drug use, HIV risk-taking behaviors, needle use, sexual behavior, STD/HIV, past adolescent injuries, age on onset of drug use, and current conflict and aggression.

The Baseline Youth and Young Adult Data include brief sexual behavior, threat of retaliation, brief symptom inventory, drug and alcohol refusal efficacy, drinking and driving (DUI), community involvement, peer influences, non-partner aggression, parental support, parent influence on drug and alcohol use, family conflict, mentors, fight self-efficacy, community violence, medical care, alcohol dependence/abuse, drug dependence/abuse, substance abuse service utilization, post traumatic stress disorder (PTSD), conduct disorder (youth) or antisocial personality disorder (young adult), legal system involvement, major depressive episodes, and mental health service utilization.

This project was an investigation into the natural course of service needs, use, and trajectories among high-risk youth and young adults with drug use who presented to an inner-city Emergency Department with multiple risk behaviors (with and without acute violent injury). Eligible participants included youth/young adults (ages 14-24) who sought care at the Hurley Medical Center (HMC) Emergency Department (ED) located in Flint, Michigan between December 19, 2009 and September 7, 2011. Consenting youth completed a self-administered computerized screening survey. All participants who self-reported past year drug use were recruited for the longitudinal study. For a comparison group, a randomly selected sample of drug using youth seeking ED care for other reasons (e.g. abdominal pain, motor vehicle crash) were selected for longitudinal study (equilibrated monthly proportionally for age/gender with the acute violent injury group). Participants in the violent injury and comparison group completed a baseline assessment during their ED visit.

Dataset 1 (DS1) contains the Baseline Screener Data of both young adults and youth. This data file has 1,448 cases and 314 variables. Each case represents an individual seeking treatment in the emergency department.

Dataset 2 (DS2) contains the Baseline Youth Data. This data file has 89 cases and 531 variables. Of these 89 cases, 51 of the youths (ages 14-17) presented to the Emergency Department with a violent injury. The remaining 38 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.

Dataset 3 (DS3) contains the Baseline Young Adult Data. This file contains 511 cases and 483 variables. Of these 511 cases, 299 of the young adults (ages 18-24) presented to the Emergency Department with a violent injury. The remaining 212 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.

The Baseline Screener Data includes demographics and information about public assistance, income, work, marital status, insurance, the injury visit, school/grades, retaliation attitudes, fights, violence, gang affiliation, weapons, partner violence, nicotine use, alcohol use, drug use, HIV risk-taking behaviors, needle use, sexual behavior, STD/HIV, past adolescent injuries, age on onset of drug use, and current conflict and aggression.

The Baseline Youth and Young Adult Data include sexual behavior, threat of retaliation, brief symptom inventory/suicide risk, drug and alcohol refusal efficacy, drinking and driving (DUI), community involvement, peer influences, non-partner aggression, parental support, parent influence on drug and alcohol use, family conflict, mentors, fight self-efficacy, community violence, sexual risk behaviors, medical care, alcohol dependence/abuse, drug dependence/abuse, substance abuse service utilization, post traumatic stress disorder (PTSD), conduct disorder (youth) or antisocial personality disorder (young adult), legal system involvement, major depressive episodes, and mental health service utilization.

The Maternal Lifestyle Study (MLS) was the largest of the NIH longitudinal studies of children with prenatal cocaine exposure (PCE). MLS was a longitudinal multi-site observational study of the long-term effects of in-utero exposure to cocaine on child development. MLS was conducted at four geographically diverse, collaborating university centers (Wayne State University, University of Tennessee at Memphis, University of Miami, and Brown University). Participants were identified during the newborn period while in the hospital. The MLS began enrollment of a longitudinal birth cohort of 1,388 infant/mother dyads in 1993. Subjects in the follow-up were seen from 1 month of age through 16 years of age. The overall purpose of the study was to investigate the effects of drug use during pregnancy on acute neonatal events and long-term physical health, social, behavioral and neurodevelopmental outcomes.

The study included five phases of data collection. The first phase examined acute effects of maternal substance use on infant health outcomes at birth. The four subsequent follow-up phases examined development across the following periods: Phase II -- 1-36 months; Phase III -- 4-7 years; Phase IV -- 8-11 years; Phase V -- 12-16 years. In Phase I, the study screened 19,079 infants between May 1993 and May 1995. Mothers at these centers were enrolled in the study within 24 hours after delivery. Initial screening included the mother's labor and delivery chart, the newborn admission chart, and a meconium sample. Infant meconium was collected and samples were express shipped to a central laboratory for analysis of metabolites of illicit drugs. Additionally, a drug use questionnaire that addressed the mother's use during pregnancy of nicotine, alcohol, marijuana, cocaine, opiates, and other illicit drugs was given by research staff that were trained and certified in the reliable administration of all of the study interviews. A mother-child dyad was considered exposed if a mother admitted to using cocaine during pregnancy and/or there was a positive meconium assay for cocaine metabolites including gas chromatography/mass spectrometry confirmation. Nonexposed children were those who were born to mothers who denied cocaine use, confirmed by negative meconium test results. Acute outcomes evaluated in Phase I included: central nervous system (CNS) and autonomic nervous system (ANS) findings and symptoms, abruption placenta, fetal growth retardation, congenital malformations, respiratory distress syndrome, chronic lung disease, intraventricular hemorrhage, necrotizing enterocolitis, retinopathy of prematurity, and periventricular leukomalacia.

From the initial Phase I cohort of 8,627 dyads, 1,388 participants for the longitudinal follow-up were recruited at a 1-month visit. The sample included a cohort of exposed infants (n = 658) who were group matched within site with a group of non-exposed comparison infants (n=730) by gestational age categories (32, 33-36, and 36 weeks) and child gender, race, and ethnicity. At the 1-month visit, the biological mother was interviewed for a detailed inventory of her legal and illegal drug use during pregnancy using the Maternal Interview of Substance Use (MISU). Phase II examined the first 36 months of life for the sample of 1,388. Follow-up visits occurred at 1, 4, 7, 9, 12, 18, 24, and 36 months (corrected age). Outcomes examined included physical health, developmental, behavioral, social, and environmental outcomes. Phase III followed children at 4, 4.5, 5, 6, and 7 years. In addition to outcomes examined in Phase II, school performance and neurodevelopmental measures of emotional and behavioral self-regulation were also examined. Phase IV covers ages 8, 9, 10, and 11 years of age. Outcomes in this phase were further expanded to include antisocial behavior, onset of substance use, psychopathology, and neuroendocrine function. Phase V assessed children at ages 12, 13, 14, 15, and 16 years of age. The fifth phase of the study has a significant emphasis on psychopathology, school performance, peer relationships, substance use onset and risk taking behaviors, including risky sexual behaviors.

The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.

The Risk Factors for AIDS among Intravenous Drug Users study is an ongoing series of cross-sectional studies that recruits participants from a storefront research site and from one of New York City's largest detoxification facilities. The goal of the study was to assess the potential effectiveness of HIV interventions by examining participants' drug use, risk behavior, and AIDS prevention knowledge and activities.

The dataset combines survey responses taken from interviews conducted at the Bellevue Methadone Maintenance Treatment Program, the Beth Israel Medical Center and from a high drug use area in Lower East Side of Manhattan. All participants were at least 18 years of age or older. Participants from the Beth Israel Medical Center and the Lower East Side were given face-to-face interviews based on a World Health Organization Multi-Centre questionnaire. Data from the Bellevue Methadone Maintenance Treatment Program were extracted from patients' clinical files. Minimal demographic and HIV risk behavior were included in the methadone patient responses in these data to protect their anonymity. Blood samples were taken from participants to test for HIV.

These data also contain information on topics including participant demographics, alcohol use, drug use, substance abuse treatment, needle sharing habits, sexual behavior, social networks, HIV testing services, as well as mental and physical health. Drugs use explored in this study includes heroin, cocaine, crack, methadone, amphetamines, ice, tranquilizers, barbiturates and other drugs.

This dataset is public-use. A restricted-use version of the dataset is also available with the associated study number 35078. There are 2,907 respondents and 902 variables in the dataset.

In the fall of 1993, the entering 1st graders in nine Baltimore City, Maryland public elementary schools were recruited for participation in a randomized trial of two universal, preventive interventions. Both interventions targeted the early antecedent risk behaviors of poor academic achievement and aggressive/coercive behavior and their distal correlates: substance abuse/dependence, antisocial behavior, high risk sexual behavior, sexually transmitted infections (STIs), and psychiatric symptoms and disorders. One intervention, the classroom-centered intervention (CC), sought to reduce the early risk behaviors of poor achievement and aggressive/coercive behaviors through the enhancement of classroom curricula and teacher instructional and behavior management practices. The second intervention, the family-school partnership intervention (FSP), sought to reduce these early risk behaviors by improving parent-teacher/school mental health professional collaboration and by enhancing parents' teaching and behavior management skills. The participating students and 1st grade teachers were randomly assigned to either the CC or FSP classroom-level conditions or to a control or standard setting classroom. The participating students' outcomes were assessed from the fall of 1st grade through 12th grade. Annual outcome assessments continued following high school through age ~ 26. Data from participating students' self-report of substance use and its putative mediators and moderators in 8th through 12th grade are available in this dataset.

The principal investigator withheld the intervention status variable that distinguishes the intervention groups from the control group. You may contact the Principal investigator to discuss obtaining the intervention variable.

This dataset contains variables on frequency of respondents' substance use during the respondents' lifetime as well as in the year, month, week prior to the survey. In addition, the dataset contains variables on alcohol consumption. The dataset also contains variables on the respondents' perceptions of the availability and harmfulness of substances. Respondents were also asked about perception of how many of his/her friends used drugs as well as their attitudes towards drug use, including personal disapproval of drug use, and perceived attitudes of parents and friends towards the respondents' drug use. Respondents were asked whether and how often they were offered substances to use and their intention to use substances if offered in the future. Substances asked about include tobacco, alcohol, marijuana, cocaine, crack, heroin, ecstasy, and inhalants.

This dataset contains 1535 variables and 713 respondents. The only demographic variables in this dataset are race and gender.

The Risk Factors for AIDS among Intravenous Drug Users study is an ongoing series of cross-sectional studies that recruits participants from a storefront research site and from one of New York City's largest detoxification facilities. The goal of the study was to assess the potential effectiveness of HIV interventions by examining participants' drug use, risk behavior, and AIDS prevention knowledge and activities.

The dataset combines survey responses taken from interviews conducted at the Bellevue Methadone Maintenance Treatment Program, the Beth Israel Medical Center and from a high drug use area in Lower East Side of Manhattan. All participants were at least 18 years of age or older. Participants from the Beth Israel Medical Center and the Lower East Side were given face-to-face interviews based on a World Health Organization Multi-Centre questionnaire. Data from the Bellevue Methadone Maintenance Treatment Program were extracted from patients' clinical files. Minimal demographic and HIV risk behavior were included in the methadone patient responses in these data to protect their anonymity. Blood samples were taken from participants to test for HIV.

These data also contain information on topics including participant demographics, alcohol use, drug use, substance abuse treatment, needle sharing habits, sexual behavior, social networks, HIV testing services, as well as mental and physical health. Drugs use explored in this study includes heroin, cocaine, crack, methadone, amphetamines, ice, tranquilizers, barbiturates and other drugs.

There are 2,907 respondents and 906 variables in the dataset.

The Network for the Improvement of Addiction Treatment (NIATx) is a program funded by the Robert Wood Johnson Foundation and the Center for Substance Abuse Treatment to help substance abuse treatment facilities improve the effectiveness and efficiency of care offered to clients. A total of 38 facilities from across the country were awarded funding to implement the NIATx program between the years of 2003 to 2007. Data were extracted from administrative records from 82,274 clients. The data file covers the dates of contact and treatment with the facility, the number of follow-up units of care received, the primary substance of abuse, and basic demographic information.

The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys.

The DC*MADS: Drug Use Among Women Delivering Livebirths in DC Hospitals was designed to examine the nature and extent of drug use among women delivering live births in eight Washington, DC, hospitals participating in the study. Data from the questionnaires include prenatal care, health problems during pregnancy, pregnancy drug use history, needle use, polysubstance use, patterns of use, respondent's general experiences with drug use, including perceptions of the risks and consequences of use, occurrence of psychological and emotional problems, income and insurance coverage, treatment experiences, and maternal and infant outcomes. Medical records were abstracted from the women and their infants to document medical problems. Abstracted data on the mothers included demographics, discharge diagnoses, disposition at discharge, and results of urine screens. Abstracted data on infants included delivery information, status at discharge, discharge diagnoses/procedures, and first urine toxicology screen results.